TSE:EXE Extendicare (EXE) Stock Forecast, Price & News C$7.11 +0.08 (+1.14%) (As of 03:02 PM ET) Add Compare Share Share Today's RangeC$6.96▼C$7.1150-Day RangeC$6.08▼C$7.2852-Week RangeC$6.02▼C$7.69Volume72,312 shsAverage Volume155,905 shsMarket CapitalizationC$600.01 millionP/E Ratio142.20Dividend Yield6.75%Price TargetC$7.50 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsInsider TradesHeadlinesSocial MediaProfileAnalyst RatingsChartCompetitorsDividendEarningsInsider TradesHeadlinesSocial Media Extendicare MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside7.3% UpsideC$7.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.60Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.01 out of 5 stars 1.0 Analyst's Opinion Consensus RatingExtendicare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$7.50, Extendicare has a forecasted upside of 7.3% from its current price of C$6.99.Amount of Analyst CoverageExtendicare has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for EXE. Previous Next 1.7 Dividend Strength Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 6.62%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Extendicare is 960.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EXE. Previous Next 2.6 News and Social Media Coverage News SentimentExtendicare has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Extendicare this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Extendicare to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by Insiders13.33% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 17.39% of the stock of Extendicare is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is 139.80, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 123.12.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is 139.80, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 90.06.Price to Book Value per Share RatioExtendicare has a P/B Ratio of 5.83. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Extendicare (TSE:EXE) StockExtendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a network of 119 LTC homes and retirement communities, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. Extendicare Inc. was founded in 1968 and is based in Markham, Canada.Read More Receive EXE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address EXE Stock News HeadlinesMay 28, 2023 | americanbankingnews.comExtendicare Inc. (EXE) To Go Ex-Dividend on May 30thMay 28, 2023 | americanbankingnews.comExtendicare (TSE:EXE) Shares Pass Above Two Hundred Day Moving Average of $6.63May 31, 2023 | Edge On The Street (Ad)The Ignored EV Story Few Investors Know AboutLithium may grab all the headlines, but the average electric vehicle requires 146 pounds of the mineral graphite. With no producing graphite mines in North America, the U.S. government is desperate for more domestic sources of the metal to feed the EV battery supply chain.May 24, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc 5 Pct Debs flat on Wednesday (EXE-DB-C)May 24, 2023 | baystreet.caBUY ALERT: Extendicare Offers Great Value and a 6.6% Monthly YieldMay 23, 2023 | ca.finance.yahoo.comWhy This Canadian Healthcare Stock Is a Hidden Value GemMay 19, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc 5 Pct Debs down on Friday (EXE-DB-C)May 16, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc down on Tuesday (EXE)May 31, 2023 | Edge On The Street (Ad)The Ignored EV Story Few Investors Know AboutLithium may grab all the headlines, but the average electric vehicle requires 146 pounds of the mineral graphite. With no producing graphite mines in North America, the U.S. government is desperate for more domestic sources of the metal to feed the EV battery supply chain.May 15, 2023 | msn.com6.6% Dividend Yield! 1 Cheap TSX Stock to Buy and Hold in May 2023May 14, 2023 | msn.comTFSA Investors: Invest $45,000 for $3,504 in Annual IncomeMay 13, 2023 | americanbankingnews.comFY2023 EPS Estimates for Extendicare Inc. Lifted by Analyst (TSE:EXE)May 12, 2023 | americanbankingnews.comExtendicare (TSE:EXE) PT Raised to C$7.50 at Royal Bank of CanadaMay 11, 2023 | americanbankingnews.comExtendicare (TSE:EXE) PT Raised to C$7.50 at National BanksharesMay 10, 2023 | finance.yahoo.comExtendicare (TSE:EXE) shareholders have earned a 16% CAGR over the last three yearsMay 10, 2023 | americanbankingnews.comFY2024 Earnings Forecast for Extendicare Inc. Issued By National Bank Financial (TSE:EXE)May 4, 2023 | finance.yahoo.comExtendicare Announces 2023 First Quarter ResultsApril 30, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc flat on Friday (EXE)April 22, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc down on Thursday (EXE)April 22, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc 5 Pct Debs flat on Friday (EXE-DB-C)April 20, 2023 | finance.yahoo.comExtendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04April 19, 2023 | americanbankingnews.comExtendicare Inc. (TSE:EXE) Plans Monthly Dividend of $0.04April 18, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc 5 Pct Debs up on Monday (EXE-DB-C)April 17, 2023 | finance.yahoo.comExtendicare Announces April 2023 Dividend of C$0.04 per ShareApril 15, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc up on Thursday (EXE)April 15, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc down on Friday (EXE)April 14, 2023 | finance.yahoo.comIs There An Opportunity With Extendicare Inc.'s (TSE:EXE) 35% Undervaluation?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive EXE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address EXE Company Calendar Last Earnings3/02/2023Ex-Dividend for 5/15 Dividend4/27/2023Dividend Payable5/15/2023Ex-Dividend for 6/15 Dividend5/30/2023Today5/31/2023Dividend Payable6/15/2023Next Earnings (Estimated)8/08/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE Industry Long - Term Care Facilities Sub-IndustryN/A SectorMedical Current SymbolTSE:EXE CUSIPN/A CIKN/A Webwww.extendicare.com Phone905-470-4000FaxN/AEmployees23,000Year FoundedN/APrice Target and Rating Average Stock Price ForecastC$7.50 High Stock Price ForecastC$8.00 Low Stock Price ForecastC$7.00 Forecasted Upside/Downside+5.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.05 Trailing P/E Ratio142.20 Forward P/E Ratio37.12 P/E GrowthN/ANet IncomeC$3.02 million Net Margins6.21% Pretax MarginN/A Return on Equity3.01% Return on Assets0.61% Debt Debt-to-Equity Ratio391.22 Current Ratio0.91 Quick Ratio0.98 Sales & Book Value Annual SalesC$1.24 billion Price / Sales0.48 Cash FlowC$2.22 per share Price / Cash Flow3.20 Book ValueC$1.20 per share Price / Book5.93Miscellaneous Outstanding Shares84,390,000Free FloatN/AMarket CapC$600.01 million OptionableNot Optionable Beta1.20 Key ExecutivesDr. Michael R. Guerriere M.D. (Age 59)MBA, CEO, Pres & Director Comp: $1.13MMr. David E. BaconSr. VP & CFOMr. John ToffolettoSr. VP, Chief Legal Officer & Corp. Sec.Ms. Leslie Sarauer (Age 61)Sr. VP & Chief HR Officer Comp: $567.15kMr. Ali Mohammad MirVP, ParaMed OperationsMr. Steve ParaskevopoulosSr. VP of ParaMed & CTOMs. Jillian E. FountainVP of Investor RelationsMs. Lisa PearsonVP of Public AffairsMs. Elaine E. EversonVP of Corp. Devel.Dr. Matthew MorganChief Medical OfficerMore ExecutivesKey CompetitorsSienna Senior LivingTSE:SIACanopy GrowthTSE:WEEDKnight TherapeuticsTSE:GUDViemed HealthcareTSE:VMDCRH MedicalTSE:CRHView All Competitors EXE Stock - Frequently Asked Questions Should I buy or sell Extendicare stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" EXE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXE, but not buy additional shares or sell existing shares. View EXE analyst ratings or view top-rated stocks. What is Extendicare's stock price forecast for 2023? 3 Wall Street analysts have issued 1 year price targets for Extendicare's stock. Their EXE share price forecasts range from C$7.00 to C$8.00. On average, they predict the company's share price to reach C$7.50 in the next twelve months. This suggests a possible upside of 5.5% from the stock's current price. View analysts price targets for EXE or view top-rated stocks among Wall Street analysts. How have EXE shares performed in 2023? Extendicare's stock was trading at C$6.56 on January 1st, 2023. Since then, EXE stock has increased by 8.4% and is now trading at C$7.11. View the best growth stocks for 2023 here. When is Extendicare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023. View our EXE earnings forecast. How were Extendicare's earnings last quarter? Extendicare Inc. (TSE:EXE) released its quarterly earnings data on Thursday, March, 2nd. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by $0.13. The business had revenue of $310.39 million for the quarter, compared to analyst estimates of $309.50 million. Extendicare had a net margin of 6.21% and a trailing twelve-month return on equity of 3.01%. How often does Extendicare pay dividends? What is the dividend yield for Extendicare? Extendicare announced a monthly dividend on Thursday, May 4th. Shareholders of record on Wednesday, May 31st will be paid a dividend of 0.04 per share on Thursday, June 15th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 6.75%. The ex-dividend date of this dividend is Tuesday, May 30th. Read our dividend analysis for EXE. Is Extendicare a good dividend stock? Extendicare (TSE:EXE) pays an annual dividend of C$0.48 per share and currently has a dividend yield of 6.62%. EXE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 960.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for EXE. What other stocks do shareholders of Extendicare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR), Martinrea International (MRE), Air Canada (AC), AltaGas (ALA) and Emera (EMA). What is Extendicare's stock symbol? Extendicare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EXE." How do I buy shares of Extendicare? Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Extendicare's stock price today? One share of EXE stock can currently be purchased for approximately C$7.11. How much money does Extendicare make? Extendicare (TSE:EXE) has a market capitalization of C$600.01 million and generates C$1.24 billion in revenue each year. The company earns C$3.02 million in net income (profit) each year or C$0.05 on an earnings per share basis. How many employees does Extendicare have? The company employs 23,000 workers across the globe. How can I contact Extendicare? The official website for the company is www.extendicare.com. The company can be reached via phone at 905-470-4000. This page (TSE:EXE) was last updated on 5/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.